Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors. [electronic resource]
- Bioorganic & medicinal chemistry letters May 2012
- 3284-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1464-3405
10.1016/j.bmcl.2012.03.019 doi
Animals Biological Availability CCR5 Receptor Antagonists Cell Line Drug Design HIV Fusion Inhibitors--chemical synthesis HIV-1--drug effects Humans Inhibitory Concentration 50 Microbial Sensitivity Tests Piperazines--chemical synthesis Piperidines--chemical synthesis Solubility Structure-Activity Relationship